Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer’s disease PSEN1 M146L mutation

PaperCitations, authors & open-access status

CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer’s disease PSEN1 M146L mutation is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 51 citations, 2022 year and gold oa status.

51
Citations
2022
Year
gold
OA Status

Related on ScholarIQ

Ximena Aguilar
Author
CRISPR and Genetic Engineering
Topic
CRISPR and Genetic Engineering
Topic
Genetics, Aging, and Longevity in Model Organisms
Topic
Alzheimer's disease research and treatments
Topic
470M+ articles · free account